Steve Niemcryk
About Steve Niemcryk
Steve Niemcryk is the Executive Director and Lead Safety Epidemiologist at BeiGene, with extensive experience in epidemiology and patient safety across several major pharmaceutical companies.
Company
Steve Niemcryk is currently employed at BeiGene, where he serves as the Executive Director and Lead Safety Epidemiologist within the Global Patient Safety Department. His role is based in North Carolina, United States. BeiGene is a global biotechnology company focused on molecularly targeted and immuno-oncology drug discovery and development programs.
Title
Steve Niemcryk holds the position of Executive Director and Lead Safety Epidemiologist at BeiGene. In this capacity, he manages the integration of epidemiology into the development process of the company. He is responsible for proposing and designing epidemiologic studies, as well as anticipating pre- and post-approval clinical safety questions.
Education and Expertise
Steve Niemcryk earned his Ph.D. in Preventive Medicine and Community Health from The University of Texas Medical Branch, where he studied from 1983 to 1988. Prior to this, he obtained a Master of Science (MS) in Human Development from The University of Texas at Dallas, completing his studies there from 1981 to 1983. His educational background has provided him with a substantial foundation in epidemiology and public health.
Professional Background
Before his current role at BeiGene, Steve Niemcryk held various significant positions in the pharmaceutical and healthcare sectors. He worked at Celgene from 2016 to 2020 as Lead Safety Epidemiologist in Summit, New Jersey. Prior to that, he spent seven years (2008-2015) at AbbVie, formerly known as Abbott Laboratories, serving as Head of Global Surveillance and Pharmacoepidemiology in Abbott Park, Illinois. From 2004 to 2008, he was a Director at Bristol-Myers Squibb, and from 1998 to 2002, he worked as an Associate Director at Bayer. His earlier career included a tenure as Branch Chief at the Health Resources & Services Administration, U.S. Department of Human Services, from 1991 to 1998.
Achievements
In his role at BeiGene, Steve Niemcryk serves as an epidemiologic expert in meetings with senior management, regulators, and outside investigators. His work involves significant contributions to the company's safety and epidemiology strategies, ensuring that pre- and post-approval clinical safety questions are addressed comprehensively. His prior roles in renowned pharmaceutical companies like AstraZeneca, Celgene, AbbVie, Bristol-Myers Squibb, and Bayer highlight his extensive experience and contributions to the field of epidemiology.